SENSEI BIO

Turning Up the Heat on Tumor Immune Response

 

Sensei Bio takes lessons from the immune system to develop highly selective therapeutics.

 

Expanding the range of immunotherapy options has been challenging for a number of reasons, including on-target/off-tumor activity, an immunosuppressive tumor microenvironment, and the cost and time constraints of personalized treatment.

Enter the TMAb Platform

 

Working with Ten Bridge Communications, we created 3D rendered imagery for Sensei Bio’s new website, showcasing how their TMAb platform discovers and develops antibodies that bind their targets only in the low-pH conditions characteristic of the tumor microenvironment.

 

Final Result

 

The resulting web experience takes viewers on a visually engaging journey into Sensei Bio’s unique offerings, while educating them on the inner workings of their foundational technology.

 
 

Let's get started.

Want to discuss your next project, or just get some further information? We'd love to chat.

Previous
Previous

Redefining What's Possible in Cystic Fibrosis Treatment

Next
Next

Using Organ-Chips to Model Parkinson's Disease